Ignite Creation Date:
2025-12-25 @ 4:58 AM
Ignite Modification Date:
2025-12-26 @ 3:59 AM
Study NCT ID:
NCT00517218
Status:
WITHDRAWN
Last Update Posted:
2008-02-11
First Post:
2007-08-14
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
This Study is Being Performed to Evaluate the Effect of Genasense on the Efficacy and the Safety of Rituximab/Fludarabine Combination Treatment in Previously Untreated Subjects With Chronic Lymphocyctic Leukemia(CLL)
Sponsor:
Genta Incorporated
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2006-06
Start Date Type:
None
Primary Completion Date:
None
Primary Completion Date Type:
None
Completion Date:
2009-06
Completion Date Type:
None
First Submit Date:
2007-08-14
First Submit QC Date:
None
Study First Post Date:
2007-08-16
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2008-02-07
Last Update Post Date:
2008-02-11
Last Update Post Date Type:
ESTIMATED